Barbour, S. J., Fervenza, F. C., Induruwage, D., Brenchley, P. E., Rovin, B., Hladunewich, M. A., Reich, H. N., Lafayette, R., Aslam, N., Appel, G. B., Zand, L., Kiryluk, K., Liu, L., & Cattran, D. C. (2023). Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy. Clinical Journal of the American Society of Nephrology, 18(10), 1283–1293. https://doi.org/10.2215/cjn.0000000000000237